News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.
All News
January 15, 2024
January 3, 2024
December 20, 2023
December 13, 2023
YourChoice Therapeutics Begins First-in-human Trial for Male Birth Control pill
December 12, 2023
October 30, 2023
Catalyst Biosciences Completes of Merger with Gyre Pharmaceuticals and Implements Name Change
October 12, 2023
Pulse 2.0
Pow.Bio Closes $9.5 Million To Develop Intelligent Continuous Fermentation Technologies
October 3, 2023
BusinessWire
September 18, 2023
August 23, 2023
July 17, 2023
July 7, 2023
July 6, 2023
June 15, 2023
May 23, 2023
May 11, 2023
May 1, 2023
March 21, 2023
March 20, 2023
Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479
December 20, 2022
- « first Full listing: News
- ‹ previous Full listing: News
- 1 of 18 Full listing: News
- 2 of 18 Full listing: News
- 3 of 18 Full listing: News (Current page)
- 4 of 18 Full listing: News
- 5 of 18 Full listing: News
- 6 of 18 Full listing: News
- 7 of 18 Full listing: News
- 8 of 18 Full listing: News
- 9 of 18 Full listing: News
- …
- next › Full listing: News
- last » Full listing: News